Reporter June 14 2019
Churchwell named interim vice chancellor for equity, diversity and inclusion and chief university diversity officer
Jun. 14, 2019—André L. Churchwell, chief diversity officer for Vanderbilt University Medical Center and senior associate dean for diversity affairs in the Vanderbilt University School of Medicine, has been named interim vice chancellor for equity, diversity and inclusion and chief diversity officer for Vanderbilt University.
New method tested to block chikungunya infection
Jun. 14, 2019—Scientists are testing a new way to fight chikungunya virus that involves injecting genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies.
Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy
Jun. 13, 2019—More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology.
$10 million gift bolsters psychosis research efforts
Jun. 13, 2019—A $10 million endowed gift will fund translational research, support clinical programs and create an endowed chair within the Department of Psychiatry.
Eng named to GI cancer leadership position at VICC
Jun. 13, 2019—Cathy Eng, MD, a national and international leader in gastrointestinal medical oncology, is joining Vanderbilt-Ingram Cancer Center (VICC).
Diversity of conference attendees mirrors increasing support for palliative care
Jun. 13, 2019—More than 80 people attended a Palliative Care Conference in Nashville recently that was led by faculty members of the Palliative Care programs at VUMC and the Nashville VA Medical Center, and VUMC Center for Biomedical Ethics.
Study seeks to expand treatment options for rare airway disease
Jun. 13, 2019—Armed with $1.2 million in funding from the National Heart, Lung and Blood Institute (NHLBI), researchers at Vanderbilt University Medical Center are searching to understand the cause of a rare airway disease in hopes of developing better treatments.
Ehrenfeld to depart VUMC for leadership roles in Wisconsin
Jun. 13, 2019—Jesse Ehrenfeld, MD, MPH, professor of Anesthesiology, Surgery, Biomedical Informatics and Health Policy, will be departing Vanderbilt to become director of the Advancing a Healthier Wisconsin (AHW) Endowment and senior associate dean at the Medical College of Wisconsin (MCW) School of Medicine effective Sept. 1.
Treatment approved for patients with acute graft-versus-host disease
Jun. 13, 2019—The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment. VUMC's Madan Jagasia, MBBS, MS, MMHC, was a lead investigator of the REACH1 trial that was the basis for the FDA approval.
Three School of Nursing faculty named first Valere Potter Distinguished Dean’s Faculty Fellows
Jun. 13, 2019—Cathy Maxwell, PhD, Shelagh Mulvaney, PhD, and Bethany Rhoten, PhD, have been named Vanderbilt University School of Nursing’s first Valere Potter Distinguished Dean’s Faculty Fellows.
Brown named executive medical director of Neurosciences Patient Care Center
Jun. 13, 2019—Kelly Brown, MD, associate professor of Clinical Neurology, will be assuming the role of executive medical director of the Neurosciences Patient Care Center (PCC) effective July 1.
Peterson appointed director of VUIIS Radiochemistry Core Lab
Jun. 13, 2019—Todd Peterson, PhD, associate professor of Radiology and Radiological Sciences, has been appointed director of the Vanderbilt University Institute of Imaging Science (VUIIS) Radiochemistry Core Lab, following the departure of Michael Nickels, PhD.
